Xarelto Internal Bleeding Suit Nixed As Time-Barred

Law360, New York (October 11, 2017, 5:19 PM EDT) -- A Louisiana federal judge on Tuesday axed a patient’s suit in multidistrict litigation accusing Johnson & Johnson unit Janssen Pharmaceuticals Inc. and Bayer HealthCare Pharmaceuticals Inc. of not warning about the risks of blood thinner Xarelto, saying he filed his claims too late.

U.S. District Judge Eldon Fallon said that Louisiana resident Herbert Louiviere had reason to believe that his gastrointestinal bleeding — for which he was twice hospitalized— was caused by the drug by March 28, 2013, but he didn’t file suit until June 2015,...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

In Re: Xarelto (Rivaroxaban) Products Liability Litigation


Case Number

2:14-md-02592

Court

Louisiana Eastern

Nature of Suit

Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability

Judge

Eldon E. Fallon

Date Filed

December 12, 2014


Case Title

Louviere v. Janssen Research & Development LLC et al


Case Number

2:15-cv-04790

Court

Louisiana Eastern

Nature of Suit

Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability

Judge

Eldon E. Fallon

Date Filed

September 25, 2015

Law Firms

Companies

Government Agencies

Judge Analytics

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.